- Home
- VCEL vs NTB Comparison
VCEL vs NTB Comparison
Compare VCEL & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- NTB
- Stock Information
- Founded
- VCEL 1989
- NTB 1858
- Country
- VCEL United States
- NTB Bermuda
- Employees
- VCEL N/A
- NTB N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- NTB Commercial Banks
- Sector
- VCEL Health Care
- NTB Finance
- Exchange
- VCEL Nasdaq
- NTB Nasdaq
- Market Cap
- VCEL 1.6B
- NTB 1.8B
- IPO Year
- VCEL 1997
- NTB 2016
- Fundamental
- Price
- VCEL $33.59
- NTB $41.98
- Analyst Decision
- VCEL Strong Buy
- NTB Hold
- Analyst Count
- VCEL 6
- NTB 3
- Target Price
- VCEL $58.60
- NTB $50.00
- AVG Volume (30 Days)
- VCEL 703.6K
- NTB 193.6K
- Earning Date
- VCEL 11-06-2025
- NTB 10-28-2025
- Dividend Yield
- VCEL N/A
- NTB 4.77%
- EPS Growth
- VCEL 2045.40
- NTB 14.60
- EPS
- VCEL 0.13
- NTB 4.96
- Revenue
- VCEL $249,119,000.00
- NTB $588,897,000.00
- Revenue This Year
- VCEL $18.35
- NTB $3.31
- Revenue Next Year
- VCEL $22.26
- NTB N/A
- P/E Ratio
- VCEL $259.38
- NTB $8.54
- Revenue Growth
- VCEL 16.13
- NTB 2.95
- 52 Week Low
- VCEL $29.24
- NTB $34.77
- 52 Week High
- VCEL $63.00
- NTB $46.89
- Technical
- Relative Strength Index (RSI)
- VCEL 52.73
- NTB 37.44
- Support Level
- VCEL $31.34
- NTB $41.14
- Resistance Level
- VCEL $35.70
- NTB $42.67
- Average True Range (ATR)
- VCEL 1.48
- NTB 0.90
- MACD
- VCEL 0.46
- NTB -0.05
- Stochastic Oscillator
- VCEL 71.12
- NTB 21.99
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.